Transaction in own shares

b'Dissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nLONDON, 13 May 2021: Arix Bioscience plc ("Arix" or "the Company") (LSE:ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it purchased the following number of its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a buyback programme announced on 22 March 2021.\nArix intends to retain the purchased shares in treasury.\nFollowing settlement of the above purchase, Arix will have 132,653,800 ordinary shares of 0.001 pence each in issue (excluding 2,955,853 ordinary shares of 0.001 pence each held in treasury).